Related Experiment Video
Updated: Jun 28, 2026

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
HDX-ESI-MS reveals enhanced conformational dynamics of the amyloidogenic protein beta(2)-microglobulin upon release
John P Hodkinson1, Thomas R Jahn, Sheena E Radford
1Astbury Centre for Structural Molecular Biology, Institute of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Abstract:
The light chain of the major histocompatibility complex class 1 (MHC-1), the protein beta(2)-microglobulin (beta(2)m), has amyloidogenic properties that arise only upon its dissociation from the MHC-1. Here hydrogen/deuterium exchange electrospray ionization mass spectrometry (HDX-ESI-MS) has been used to compare the solution dynamics of beta(2)m in its MHC-1 bound state compared with those of beta(2)m as a free monomer. The capability of tandem mass spectrometry to dissociate the MHC-1 into its individual constituents in the gas phase following deuterium incorporation in solution has permitted the direct observation of the exchange properties of MHC-1 bound beta(2)m for the first time. The HDX-ESI-MS data show clearly that the H-->D exchange of MHC-1 bound beta(2)m follows EX2 kinetics and that about 20 protons remain protected from exchange after 17 days. Free from the MHC-1, monomeric beta(2)m exhibits significantly different HDX behavior, which encompasses both EX1 and EX2 kinetics. The EX2 kinetics indicate a tenfold increase in the rate of exchange compared with MHC-1 bound beta(2)m, with just 10 protons remaining protected from EX2 exchange and therefore exchanging only via the EX1 mechanism. The EX1 kinetics observed for unbound beta(2)m are consistent with unfolding of its exchange-protected core with a t(1/2) of 68 min (pH 7, 37 degrees C). Thus, upon dissociation from the stabilizing influence of the MHC-1, free beta(2)m becomes highly dynamic and undergoes unfolding transitions that result in an aggregation-competent protein.
Insights
Beta(2)-microglobulin (beta(2)m) becomes amyloidogenic when unbound from MHC-1. Hydrogen/deuterium exchange mass spectrometry revealed that free beta(2)m unfolds rapidly, leading to aggregation.
Area of Science:
- Biochemistry
- Structural Biology
- Mass Spectrometry
Background:
- Beta(2)-microglobulin (beta(2)m) is the light chain of MHC-1.
- Beta(2)m exhibits amyloidogenic properties upon dissociation from MHC-1.
- Understanding beta(2)m's dynamics is crucial for amyloidosis research.
Purpose of the Study:
- To compare the solution dynamics of MHC-1 bound beta(2)m versus free monomeric beta(2)m.
- To investigate the structural changes of beta(2)m upon dissociation from MHC-1.
- To elucidate the mechanism of beta(2)m aggregation.
Main Methods:
- Hydrogen/deuterium exchange electrospray ionization mass spectrometry (HDX-ESI-MS).
- Tandem mass spectrometry for gas-phase dissociation of MHC-1.
- Kinetic analysis of H-->D exchange (EX1 and EX2 kinetics).
Main Results:
- MHC-1 bound beta(2)m follows EX2 kinetics with ~20 protected protons.
- Free monomeric beta(2)m exhibits both EX1 and EX2 kinetics.
- Free beta(2)m shows a tenfold increase in exchange rate and unfolds with a t(1/2) of 68 min.
- ~10 protons remain protected from EX2 exchange in free beta(2)m.
Conclusions:
- Dissociation from MHC-1 renders beta(2)m highly dynamic.
- Free beta(2)m undergoes unfolding transitions.
- These transitions lead to an aggregation-competent state of beta(2)m.
More Related Videos
10:24Defining Hsp33's Redox-regulated Chaperone Activity and Mapping Conformational Changes on Hsp33 Using Hydrogen-deuterium Exchange Mass Spectrometry
Published on: June 7, 2018
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
Related Concept Videos
Export of Misfolded Proteins out of the ER
Huntington Disease l: Introduction
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...